lactulose and rifampin
lactulose has been researched along with rifampin in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baker, DE | 1 |
| Barroso, EC; Bushen, OY; Façanha, MC; Guerrant, RL; Lima, AA; Monteiro, HS; Peloquin, CA; Pinheiro, VG; Ramos, LM | 1 |
| Beganović, J; Frece, J; Kos, B; Lebos, A; Susković, J; Svetec, IK; Zgaga, Z | 1 |
Reviews
2 review(s) available for lactulose and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Rifaximin: a nonabsorbed oral antibiotic.
Topics: Anti-Infective Agents; Diarrhea; Escherichia coli Infections; Gases; Hepatic Encephalopathy; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Intestines; Lactulose; Microbial Sensitivity Tests; Rifampin; Rifamycins; Rifaximin | 2005 |
Other Studies
4 other study(ies) available for lactulose and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Female; Humans; Intestinal Absorption; Isoniazid; Lactulose; Male; Mannitol; Middle Aged; Permeability; Rifampin; Tuberculosis, Pulmonary | 2006 |
Synbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice.
Topics: Animals; Antibiotics, Antitubercular; Bacterial Adhesion; Drug Resistance, Bacterial; Female; Gastrointestinal Tract; Immune System; Inulin; Lactobacillus helveticus; Lactulose; Mice; Polysaccharides; Probiotics; Raffinose; Rifampin | 2009 |